BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19651773)

  • 1. Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion.
    Naismith TV; Dalal S; Hanson PI
    J Biol Chem; 2009 Oct; 284(41):27866-27874. PubMed ID: 19651773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Torsin ATPases by LAP1 and LULL1.
    Zhao C; Brown RS; Chase AR; Eisele MR; Schlieker C
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):E1545-54. PubMed ID: 23569223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding.
    Zhu L; Millen L; Mendoza JL; Thomas PJ
    J Biol Chem; 2010 Nov; 285(48):37271-80. PubMed ID: 20861018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein.
    Goodchild RE; Dauer WT
    J Cell Biol; 2005 Mar; 168(6):855-62. PubMed ID: 15767459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier.
    Kock N; Naismith TV; Boston HE; Ozelius LJ; Corey DP; Breakefield XO; Hanson PI
    Hum Mol Genet; 2006 Apr; 15(8):1355-64. PubMed ID: 16537570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-synaptic release deficits in a DYT1 dystonia mouse model.
    Yokoi F; Cheetham CC; Campbell SL; Sweatt JD; Li Y
    PLoS One; 2013; 8(8):e72491. PubMed ID: 23967309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular defects of the dystonia-causing torsinA mutation.
    Pham P; Frei KP; Woo W; Truong DD
    Neuroreport; 2006 Nov; 17(16):1725-8. PubMed ID: 17047461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane defects and genetic redundancy: Are we at a turning point for DYT1 dystonia?
    Cascalho A; Jacquemyn J; Goodchild RE
    Mov Disord; 2017 Mar; 32(3):371-381. PubMed ID: 27911022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.
    Goodchild RE; Kim CE; Dauer WT
    Neuron; 2005 Dec; 48(6):923-32. PubMed ID: 16364897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
    Goodchild RE; Dauer WT
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):847-52. PubMed ID: 14711988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsins: not your typical AAA+ ATPases.
    Rose AE; Brown RS; Schlieker C
    Crit Rev Biochem Mol Biol; 2015; 50(6):532-49. PubMed ID: 26592310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.
    Zacchi LF; Wu HC; Bell SL; Millen L; Paton AW; Paton JC; Thomas PJ; Zolkiewski M; Brodsky JL
    J Biol Chem; 2014 May; 289(18):12727-47. PubMed ID: 24627482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
    Hewett JW; Nery FC; Niland B; Ge P; Tan P; Hadwiger P; Tannous BA; Sah DW; Breakefield XO
    Hum Mol Genet; 2008 May; 17(10):1436-45. PubMed ID: 18258738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LULL1 retargets TorsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation.
    Vander Heyden AB; Naismith TV; Snapp EL; Hodzic D; Hanson PI
    Mol Biol Cell; 2009 Jun; 20(11):2661-72. PubMed ID: 19339278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.
    Nery FC; Zeng J; Niland BP; Hewett J; Farley J; Irimia D; Li Y; Wiche G; Sonnenberg A; Breakefield XO
    J Cell Sci; 2008 Oct; 121(Pt 20):3476-86. PubMed ID: 18827015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics.
    Hewett JW; Zeng J; Niland BP; Bragg DC; Breakefield XO
    Neurobiol Dis; 2006 Apr; 22(1):98-111. PubMed ID: 16361107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.
    Torres GE; Sweeney AL; Beaulieu JM; Shashidharan P; Caron MG
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15650-5. PubMed ID: 15505207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant expression, purification, and comparative characterization of torsinA and its torsion dystonia-associated variant Delta E-torsinA.
    Kustedjo K; Deechongkit S; Kelly JW; Cravatt BF
    Biochemistry; 2003 Dec; 42(51):15333-41. PubMed ID: 14690443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access of torsinA to the inner nuclear membrane is activity dependent and regulated in the endoplasmic reticulum.
    Goodchild RE; Buchwalter AL; Naismith TV; Holbrook K; Billion K; Dauer WT; Liang CC; Dear ML; Hanson PI
    J Cell Sci; 2015 Aug; 128(15):2854-65. PubMed ID: 26092934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human torsinA and its dystonia-associated mutant form.
    Liu Z; Zolkiewska A; Zolkiewski M
    Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.